169 related articles for article (PubMed ID: 36965792)
1. An updated review of diffuse mesothelioma of the pleura - A sentinel health event of potential elongate mineral particle pathogenicity.
Smith SR
Environ Res; 2023 Aug; 230():115608. PubMed ID: 36965792
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
3. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
Garabrant DH; Pastula ST
Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
[TBL] [Abstract][Full Text] [Related]
4. Non-asbestiform elongate mineral particles and mesothelioma risk: Human and experimental evidence.
Goodman JE; Becich MJ; Bernstein DM; Case BW; Mandel JH; Nel AE; Nolan R; Odo NU; Smith SR; Taioli E; Gibbs G
Environ Res; 2023 Aug; 230():114578. PubMed ID: 36965797
[TBL] [Abstract][Full Text] [Related]
5. Asbestiform fibers and cleavage Fragments: Conceptual approaches for differentiation in laboratory practice and data analysis.
Chatfield EJ
Environ Res; 2023 Aug; 230():114529. PubMed ID: 36965795
[TBL] [Abstract][Full Text] [Related]
6. Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.
Roggli VL
Toxicol Appl Pharmacol; 2018 Dec; 361():14-17. PubMed ID: 29959999
[TBL] [Abstract][Full Text] [Related]
7. Differential responses of murine alveolar macrophages to elongate mineral particles of asbestiform and non-asbestiform varieties: Cytotoxicity, cytokine secretion and transcriptional changes.
Khaliullin TO; Kisin ER; Guppi S; Yanamala N; Zhernovkov V; Shvedova AA
Toxicol Appl Pharmacol; 2020 Dec; 409():115302. PubMed ID: 33148505
[TBL] [Abstract][Full Text] [Related]
8. Measurement of elongate mineral particles: What we should measure and how do we do it?
Chatfield EJ
Toxicol Appl Pharmacol; 2018 Dec; 361():36-46. PubMed ID: 30134140
[TBL] [Abstract][Full Text] [Related]
9. Dimensions of elongate mineral particles and cancer: A review.
Wylie AG; Korchevskiy AA
Environ Res; 2023 Aug; 230():114688. PubMed ID: 36965798
[TBL] [Abstract][Full Text] [Related]
10. Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2022; 34(1-2):24-38. PubMed ID: 35001771
[No Abstract] [Full Text] [Related]
11. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
12. The risk of mesothelioma from exposure to chrysotile asbestos.
Yarborough CM
Curr Opin Pulm Med; 2007 Jul; 13(4):334-8. PubMed ID: 17534182
[TBL] [Abstract][Full Text] [Related]
13. Modeling mesothelioma risk factors from amphibole fiber dimensionality: mineralogical and epidemiological perspective.
Wylie AG; Korchevskiy A; Segrave AM; Duane A
J Appl Toxicol; 2020 Apr; 40(4):515-524. PubMed ID: 32040984
[TBL] [Abstract][Full Text] [Related]
14. Mesothelioma and other lung disease in taconite miners; the uncertain role of non-asbestiform EMP.
Mandel JH; Odo NU
Toxicol Appl Pharmacol; 2018 Dec; 361():107-112. PubMed ID: 29653125
[TBL] [Abstract][Full Text] [Related]
15. Asbestos and Other Hazardous Fibrous Minerals: Potential Exposure Pathways and Associated Health Risks.
Berry TA; Belluso E; Vigliaturo R; Gieré R; Emmett EA; Testa JR; Steinhorn G; Wallis SL
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409711
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor.
Asgharian B; Owen TP; Kuempel ED; Jarabek AM
Toxicol Appl Pharmacol; 2018 Dec; 361():27-35. PubMed ID: 29738812
[TBL] [Abstract][Full Text] [Related]
17. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
18. Dimensional determinants for the carcinogenic potency of elongate amphibole particles.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2021; 33(6-8):244-259. PubMed ID: 34612763
[TBL] [Abstract][Full Text] [Related]
19. [Asbestos exposure and related diseases among friction products workers (1971-2016)].
Barbieri PG; Mirabelli D; Madeo E; Somigliana A
G Ital Med Lav Ergon; 2020 Sep; 42(3):145-152. PubMed ID: 33119974
[TBL] [Abstract][Full Text] [Related]
20. Cancer mortality in a population exposed to nephrite processing.
Yang HY; Huang SH; Shie RH; Chen PC
Occup Environ Med; 2016 Aug; 73(8):528-36. PubMed ID: 27302977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
